Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M KORMAN

Showing results (171-180 of 206) with videos related to

Pageof 21
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 7, 2004
Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibilityBenjamin P Howden, Peter B Ward, Patrick G P Charles, et al.
Journal of Clinical Microbiology|July 18, 2014
Genetic and molecular predictors of high vancomycin MIC in Staphylococcus aureus bacteremia isolatesNatasha E Holmes, John D Turnidge, Wendy J Munckhof, et al.
Plastic and Reconstructive Surgery|May 9, 2014
A randomized controlled trial of the embrace advanced scar therapy device to reduce incisional scar formationMichael T Longaker, Rod J Rohrich, Lauren Greenberg, et al.
Plos One|July 23, 2013
Influenza vaccine effectiveness against hospitalisation with confirmed influenza in the 2010-11 seasons: a test-negative observational studyAllen C Cheng, Mark Holmes, Louis B Irving, et al.
Clinical Cardiology|March 24, 2018
Stem-cell therapy in ST-segment elevation myocardial infarction with reduced ejection fraction: A multicenter, double-blind randomized trialJosé C Nicolau, Remo H M Furtado, Suzana A Silva, et al.
Communicable Diseases Intelligence Quarterly Report|September 16, 2014
Influenza epidemiology, vaccine coverage and vaccine effectiveness in sentinel Australian hospitals in 2013: the Influenza Complications Alert NetworkAllen C Cheng, Dominic E Dwyer, Mark Holmes, et al.
Journal of Clinical Microbiology|August 28, 2020
Laboratory-Based Surveillance of Clostridium difficile Infection in Australian Health Care and Community Settings, 2013 to 2018Stacey Hong, Papanin Putsathit, Narelle George, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 20, 2015
Emergence and spread of predominantly community-onset Clostridium difficile PCR ribotype 244 infection in Australia, 2010 to 2012D W Eyre, L Tracey, B Elliott, et al.
ACS Sensors|July 17, 2020
Rapid Gel Card Agglutination Assays for Serological Analysis Following SARS-CoV-2 Infection in HumansDiana Alves, Rodrigo Curvello, Edward Henderson, et al.
Archives of Dermatological Research|July 23, 2024
The effect of histopathologic analysis and tissue cultures on inpatient management of cellulitis: a randomized control trialMichael Lause, Emma Hansen, Karissa Libson, et al.
Pageof 21

Showing results (171-180 of 206) with videos related to

Sort By:
Pageof 21
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 7, 2004
Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibilityBenjamin P Howden, Peter B Ward, Patrick G P Charles, et al.
Journal of Clinical Microbiology|July 18, 2014
Genetic and molecular predictors of high vancomycin MIC in Staphylococcus aureus bacteremia isolatesNatasha E Holmes, John D Turnidge, Wendy J Munckhof, et al.
Plastic and Reconstructive Surgery|May 9, 2014
A randomized controlled trial of the embrace advanced scar therapy device to reduce incisional scar formationMichael T Longaker, Rod J Rohrich, Lauren Greenberg, et al.
Plos One|July 23, 2013
Influenza vaccine effectiveness against hospitalisation with confirmed influenza in the 2010-11 seasons: a test-negative observational studyAllen C Cheng, Mark Holmes, Louis B Irving, et al.
Clinical Cardiology|March 24, 2018
Stem-cell therapy in ST-segment elevation myocardial infarction with reduced ejection fraction: A multicenter, double-blind randomized trialJosé C Nicolau, Remo H M Furtado, Suzana A Silva, et al.
Communicable Diseases Intelligence Quarterly Report|September 16, 2014
Influenza epidemiology, vaccine coverage and vaccine effectiveness in sentinel Australian hospitals in 2013: the Influenza Complications Alert NetworkAllen C Cheng, Dominic E Dwyer, Mark Holmes, et al.
Journal of Clinical Microbiology|August 28, 2020
Laboratory-Based Surveillance of Clostridium difficile Infection in Australian Health Care and Community Settings, 2013 to 2018Stacey Hong, Papanin Putsathit, Narelle George, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 20, 2015
Emergence and spread of predominantly community-onset Clostridium difficile PCR ribotype 244 infection in Australia, 2010 to 2012D W Eyre, L Tracey, B Elliott, et al.
ACS Sensors|July 17, 2020
Rapid Gel Card Agglutination Assays for Serological Analysis Following SARS-CoV-2 Infection in HumansDiana Alves, Rodrigo Curvello, Edward Henderson, et al.
Archives of Dermatological Research|July 23, 2024
The effect of histopathologic analysis and tissue cultures on inpatient management of cellulitis: a randomized control trialMichael Lause, Emma Hansen, Karissa Libson, et al.
Pageof 21